Minor collagens of the skin with not so minor functions.

J Anat

Centre for Cell Biology and Cutaneous Research, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Published: August 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The structure and function of the skin relies on the complex expression pattern and organisation of extracellular matrix macromolecules, of which collagens are a principal component. The fibrillar collagens, types I and III, constitute over 90% of the collagen content within the skin and are the major determinants of the strength and stiffness of the tissue. However, the minor collagens also play a crucial regulatory role in a variety of processes, including cell anchorage, matrix assembly, and growth factor signalling. In this article, we review the expression patterns, key functions and involvement in disease pathogenesis of the minor collagens found in the skin. While it is clear that the minor collagens are important mediators of normal tissue function, homeostasis and repair, further insight into the molecular level structure and activity of these proteins is required for translation into clinical therapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637451PMC
http://dx.doi.org/10.1111/joa.12584DOI Listing

Publication Analysis

Top Keywords

minor collagens
16
collagens skin
8
minor
5
collagens
5
skin
4
skin minor
4
minor functions
4
functions structure
4
structure function
4
function skin
4

Similar Publications

A Human Progenitor Cell-Based Tissue Engineered Intervertebral Disc.

Tissue Eng Part A

September 2025

Department of Orthopaedic Surgery, McKay Orthopaedic Research Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Cell and tissue engineering therapies provide promise for regenerating damaged intervertebral disc (IVD) tissue and resolving the low back pain that often accompanies it. However, these treatments remain experimental and unavailable for patients. Furthermore, the large body of work characterizing and utilizing mesenchymal stromal cells (MSCs) for these applications has, unfortunately, not resulted in any FDA-approved spinal therapies.

View Article and Find Full Text PDF

Results of a New Patch to Externally Reinforce Colorectal Anastomosis: An Experimental Study.

J Surg Res

September 2025

General Surgery Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Surgery and Morphological Sciences, Universitat Autònoma de Barcelona, School of Medicine, Bellaterra, Barcelona, Spain.

Introduction: Anastomotic leak (AL) is a serious complication in colorectal surgery, associated with increased morbidity, mortality, and healthcare costs. Technological advances have yet to eliminate AL, which occurs from 5% to 14% of cases involving anastomosis. This study introduces and evaluates a new collagen-cyanoacrylate patch designed to externally reinforce colonic anastomoses with the aim to contain anastomotic leaks.

View Article and Find Full Text PDF

Objective: The myodural bridge complex (MDBC) is a tendon-like structure highly conserved during vertebrate evolution, suggesting it plays an important physiological role. Substantial evidence indicates that the MDBC may contribute to cerebrospinal fluid (CSF) circulation by generating mechanical force. Studying its developmental process may offer new insights into CSF dynamics and lead to improved strategies for diagnosing and treating neurodegenerative diseases.

View Article and Find Full Text PDF

In this study, nanofibrous scaffolds composed of Polycaprolactone/Collagen (PCL/COL) infused with FeO/Lanthanum/SiO nanocomposite were developed. FeO and La-doped FeO nanoparticles were synthesized using a straightforward co-precipitation method. Silica extracted from Ulmus leaves via green synthesis was used to coat the FeO-La nanocomposite.

View Article and Find Full Text PDF

Alport syndrome is a hereditary glomerular disease driven by pathogenic variants in COL4A3-COL4A5 that compromise the α3-α4-α5 type IV collagen scaffold, manifesting as persistent hematuria, proteinuria, and ultimately end-stage renal disease. Its pronounced phenotypic variability, low sensitivity of renal biopsy, and limited response to ACE inhibitors complicate accurate diagnosis and therapy. In a cohort of 40 pedigrees from southwest China, we discovered 21 novel COL4A3-COL4A5 mutations.

View Article and Find Full Text PDF